Use of a PDE4 inhibitor in the manufacture of a controlled release Preparation; controlled release Formulation for the treatment of COPDA process for their Preparation and Pharmaceutical composition

摘要

This invention relates to a controlled or sustained release formulation designed to deliver a PDE4 inhibitor for treating an inflammatory disease such as asthma or COPD and the like.